Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-22-032631

Options or other derivatives

  • Chief Financial Officer acquired 1,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Howe Jill Ann · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-11-14 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +1,000,000 1,000,000 D
Loading xslF345X03/ownership.xml…